These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 10536315)

  • 1. Relationship of low-dose aspirin to GI injury and occult bleeding: a pilot study.
    Greenberg PD; Cello JP; Rockey DC
    Gastrointest Endosc; 1999 Nov; 50(5):618-22. PubMed ID: 10536315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
    Rozen P; Knaani J; Samuel Z
    Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fecal occult blood tests for detection of gastrointestinal bleeding in pediatric patients.
    Rosenthal P; Jennings MT
    Am J Gastroenterol; 1992 Nov; 87(11):1575-9. PubMed ID: 1442676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    Feldman M; Cryer B; Mallat D; Go MF
    Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease.
    Greenberg PD; Cello JP; Rockey DC
    Am J Med; 1996 Jun; 100(6):598-604. PubMed ID: 8678078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated.
    Gopalswamy N; Stelling HP; Markert RJ; Maimon HN; Wahlen SD; Haddy RI
    Arch Fam Med; 1994 Dec; 3(12):1043-8. PubMed ID: 7804488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,300 mg of aspirin daily does not cause positive fecal hemoccult tests.
    Norfleet RG
    J Clin Gastroenterol; 1983 Apr; 5(2):123-5. PubMed ID: 6304182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
    Fiorucci S; Santucci L; Gresele P; Faccino RM; Del Soldato P; Morelli A
    Gastroenterology; 2003 Mar; 124(3):600-7. PubMed ID: 12612897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of fecal occult-blood tests for colorectal-cancer screening.
    Allison JE; Tekawa IS; Ransom LJ; Adrain AL
    N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
    Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
    N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests.
    Harewood GC; McConnell JP; Harrington JJ; Mahoney DW; Ahlquist DA
    Mayo Clin Proc; 2002 Jan; 77(1):23-8. PubMed ID: 11794453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the effects of oral iron supplementation on in vivo Hemoccult stool testing.
    Anderson GD; Yuellig TR; Krone RE
    Am J Gastroenterol; 1990 May; 85(5):558-61. PubMed ID: 2186616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study.
    Kawai T; Watanabe M; Yamashina A
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S23-30. PubMed ID: 20586861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?
    Endo H; Kato T; Sakai E; Taniguchi L; Arimoto J; Kawamura H; Higurashi T; Ohkubo H; Nonaka T; Taguri M; Inamori M; Yamanaka T; Sakaguchi T; Hata Y; Nagase H; Nakajima A
    J Gastroenterol; 2017 Feb; 52(2):194-202. PubMed ID: 27095444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of new occult blood tests for detection of colorectal neoplasia.
    St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
    Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.